Back
Bone Biologics Corp. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
40
BBLG
Bone Biologics Corp.
Last Price:
$2.01
Seasonality Move:
-35.57%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiBone Biologics Corp. Stock Forecast
-
Is Bone Biologics Corp. Stock Undervalued?The current Bone Biologics Corp. [BBLG] share price is $2.03. The Score for BBLG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
BBLG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Bone Biologics Corp. Stock Go Up Next Year?
Data Unavailable
Bone Biologics Corp. Stock Rating
Data Unavailable
Bone Biologics Corp. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bonebiologics.com
52-Week Data
52-Week High:
7.74
52-Week Low:
1.30
Prediction Charts
Market Cap:
1.1M
Price in USD:
2.03
Volume:
18.9K
Beta:
0.37
Technical Analysis
SMA50:
2.02
SMA100:
2.19
SMA200:
3.33
52-Wk Change:
-70.37%
Stock Predictions
-
Is Bone Biologics Corp. stock public?Yes, Bone Biologics Corp. is a publicly traded company.
-
What is the Bone Biologics Corp. stock quote today?The Bone Biologics Corp. stock price is 2.03 USD today.
-
How to buy Bone Biologics Corp. stock online?You can buy Bone Biologics Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-24 | 1.37 | 1.36 | 1.39 | 1.33 |
| Nov-25 | 1.34 | 1.41 | 1.47 | 1.34 |
| Nov-26 | 1.46 | 1.42 | 1.61 | 1.42 |
| Nov-28 | 1.50 | 1.50 | 1.57 | 1.48 |
| Dec-1 | 1.53 | 1.52 | 1.57 | 1.50 |
| Dec-2 | 1.47 | 1.60 | 1.63 | 1.47 |
| Dec-3 | 1.51 | 1.76 | 1.77 | 1.50 |
| Dec-4 | 1.73 | 1.77 | 1.77 | 1.70 |
| Dec-5 | 1.77 | 1.93 | 1.99 | 1.71 |
| Dec-8 | 1.93 | 1.89 | 1.95 | 1.85 |
| Dec-9 | 1.84 | 2.11 | 2.16 | 1.84 |
| Dec-10 | 2.08 | 2.10 | 2.11 | 1.92 |
| Dec-11 | 2.03 | 1.90 | 2.05 | 1.88 |
| Dec-12 | 1.92 | 2.03 | 2.03 | 1.92 |
Bone Biologics Corp. Earnings
Data Unavailable
Bone Biologics Corp. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $27.64 per share, and an increase next year of $1.00 per share.
* Bone Biologics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.